Abstract
The aims of this randomized, double-blind, three-arm, single-dose study were to demonstrate pharmacokinetic (PK) equivalence of the adalimumab biosimi......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
